Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

Document and Entity Information - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2022
Dec. 16, 2022
Mar. 31, 2022
Document and Entity Information      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Sep. 30, 2022    
Entity File Number 001-35963    
Entity Registrant Name NEUBASE THERAPEUTICS, INC.    
Entity Incorporation, State Code DE    
Entity Tax Identification Number 46-5622433    
Entity Address, Address Line One 350 Technology Drive,    
Entity Address, City or Town Pittsburgh    
Entity Address, State or Province PA    
Entity Address, Postal Zip Code 15219    
City Area Code 412    
Local Phone Number 763-3350    
Title of 12(b) Security Common Stock, $0.0001 par value per share    
Trading Symbol NBSE    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity's Reporting Status Current Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   33,008,657  
Entity Public Float     $ 57.9
Entity Central Index Key 0001173281    
Current Fiscal Year End Date --09-30    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false    
Auditor Name Marcum LLP    
Auditor Location New York, NY    
Auditor Firm ID 688